Impact Proteomics

Impact Proteomics, founded with the mission to revolutionize protein, peptide, and proteome sample preparation, offers comprehensive solutions for any starting sample and final application. The company focuses on providing advanced technologies such as their patented ProMTag and the IP-to-MS platform, which is the first unbiased antigen discovery platform. Their services cater to researchers and institutions in the fields of proteomics and multiomics, aiming to drive innovation in immune profiling and other related areas.

Notable figures associated with Impact Proteomics include leading scientists and industry experts who have contributed to its technological advancements. The company has secured investments from prominent venture capital firms specializing in biotech innovations. Key achievements include the successful development and deployment of their IP-to-MS platform, which has significantly impacted the field of antigen discovery. Overall, Impact Proteomics has established itself as a pivotal player in advancing proteomic research and applications.